CIPLA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > cipla

Technical Analysis

Technical Strength: 8.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 59.9. According to RSI analysis, cipla is technically strong. 9.0 CIPLA RSI Chart
MACD (?) MACD: 10.9 and Signal Line: 8.23. According to MACD analysis, cipla is technically strong. 8.0 CIPLA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, cipla is in a strong uptrend. Major support levels are 590.25, 574.672, 569.4375. 10.0 CIPLA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, cipla is in a strong uptrend. Major support levels are 592.1103, 578.7217, 567.6124. 10.0 CIPLA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.818. According to bollinger bands, cipla is technically strong. 7.0 CIPLA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 600.5459 and 589.625. Resistance level is 635.9. 6.5 CIPLA Fibonacci Retracement Chart
Average True Range (?) ATR: 15.6 NA CIPLA Average True Range Chart
Average Directional Index (?) ADX is 20.3 which means CIPLA is in a trading range and there is no trend. NA CIPLA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 19, 2017
Open Price 613.95
High Price 613.95
Low Price 602.05
Close Price 607.8
Absolute Change -3.2
Percentage Change -0.524%
Weekly Change 3.08%
Monthly Change 6.69%
Yearly Change 3.72%
52-week high 635.9
52-week low 480.2
Corporate Actions
ExDate Purpose
July 26, 2017 AGM/DIV-RS 2/- PER SHARE
September 12, 2016 AGM/DIV RS 2/- PER SHARE
August 11, 2015 AGM/DIV-RS 2 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.597
Confidence in Beta1.18%
Market Capital Rs. 48808.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 18.89
TTM Price-to-Earnings (P/E) Ratio 32.2
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 October 2017: Deliverable Quantity:3.43e+04 NA CIPLA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 October 2017: Daily Volatility:0.3343 NA CIPLA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 October 2017: PCR_OI:0.307 PCR:0.178 NA CIPLA PCR Chart
Option Pain (?) 19 October 2017: Max Pain:600.0 NA CIPLA Option Pain Chart
Premium (?) 19 October 2017 Premium: 1.15 Futures OI:7428000.0 NA CIPLA Premium Chart
Option_MAX_OI (?) 19 October 2017: Price:607.8 Put with maximum OI:600.0 Call with maximum OI:620.0 NA CIPLA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
October 26, 2017 608.95 7428000.0 331.0 352.0 607.8
November 30, 2017 612.2 390000.0 22.0 23.0 607.8

Announcements

October 17, 2017 CiplaAnalysts/Institutional Investor Meet/Con. Call Updatesa Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
October 16, 2017 CiplaAnalysts/Institutional Investor Meet/Con. Call Updatesa Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 10, 2017 November 07, 2017 interResultsr-alia to consider and approve unaudited Financial Results ( Standalone and Consolidated) for the quarter and half year ended September 30, 2017.
July 19, 2017 August 11, 2017 InterResultsr alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2017.
See all Board Meetings

CIPLA is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 590 Rs. 596 Rs. 601.9 Rs. 607.9 Rs. 613.8 Rs. 619.8 Rs. 625.7